Suppr超能文献

与D1受体激动剂SKF 38393联合处理可揭示B-HT 958对突触后D2-多巴胺受体的刺激作用。

Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.

作者信息

Andén N E, Grabowska-Andén M

机构信息

Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.

出版信息

J Pharm Pharmacol. 1989 Jul;41(7):490-2. doi: 10.1111/j.2042-7158.1989.tb06508.x.

Abstract

The motor activity of reserpine-treated mice was used to study effects of B-HT 958 (2-amino-6-(p-chlorobenzyl)-4H-5,6,7,8-tetrahydrothiazolo-[5,4-d]- azepine) on postsynaptic dopamine and noradrenaline receptors. The motor activity was only slightly stimulated by B-HT 958 or by the D1- receptor agonist SKF 38393 but it was markedly increased by the two drugs given in combination. The effect of B-HT 958 peaked earlier following low rather than high doses. The enhanced motor activity was inhibited by the D2- receptor antagonist sulpiride or the D1- receptor antagonist SCH 23390, indicating that it was caused by stimulation of both receptor types. The results suggest that B-HT 958 stimulates postsynaptic D2- receptors in addition to D2- autoreceptors and that its blockade of postsynaptic alpha 2-adrenoceptors is of no importance for the motor activity.

摘要

利血平处理过的小鼠的运动活性被用于研究B-HT 958(2-氨基-6-(对氯苄基)-4H-5,6,7,8-四氢噻唑并-[5,4-d]-氮杂卓)对突触后多巴胺和去甲肾上腺素受体的作用。B-HT 958或D1受体激动剂SKF 38393仅轻微刺激运动活性,但两种药物联合使用时运动活性显著增加。低剂量时B-HT 958的作用峰值出现得比高剂量时更早。增强的运动活性被D2受体拮抗剂舒必利或D1受体拮抗剂SCH 23390抑制,表明其是由两种受体类型的刺激引起的。结果表明,B-HT 958除了刺激D2自身受体外,还刺激突触后D2受体,并且其对突触后α2肾上腺素受体的阻断对运动活性并不重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验